Cargando…

Non-Small Cell Lung Cancer Treatment with Molecularly Targeted Therapy and Concurrent Radiotherapy—A Review

Lung cancer is the leading cause of death worldwide for both men and women. Surgery can be offered as a radical treatment at stages I and II and selected cases of stage III (III A). Whereas at more advanced stages, combined modalities of treatment are applied: radiochemotherapy (IIIB) and molecularl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Król, Katarzyna, Mazur, Anna, Stachyra-Strawa, Paulina, Grzybowska-Szatkowska, Ludmiła
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052930/ https://www.ncbi.nlm.nih.gov/pubmed/36982933 http://dx.doi.org/10.3390/ijms24065858

Ejemplares similares

Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis
por: Szatkowska, Lidia, et al.
Publicado: (2022)

The Role of Mitochondria in Carcinogenesis
por: Kozakiewicz, Paulina, et al.
Publicado: (2021)

Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland
por: Grzybowska-Szatkowska, Ludmiła, et al.
Publicado: (2014)

Evaluation of radiotherapy combined with targeted therapy and concurrent radiotherapy, chemotherapy in the treatment of Non-Small Cell Lung Cancer with brain metastasis
por: Sun, Yanfeng, et al.
Publicado: (2020)

The Role of Prognostic Factors in Salivary Gland Tumors Treated by Surgery and Adjuvant Radio- or Chemoradiotherapy – A Single Institution Experience
por: Kordzińska-Cisek, Izabela, et al.
Publicado: (2020)

The Expression of Signaling Genes in Breast Cancer Cells
por: Rzymowska, Jolanta, et al.
Publicado: (2022)

Mitochondrial DNA Changes in Genes of Respiratory Complexes III, IV and V Could Be Related to Brain Tumours in Humans
por: Kozakiewicz, Paulina, et al.
Publicado: (2022)

Novel mitochondrial mutations in the ATP6 and ATP8 genes in patients with breast cancer
por: GRZYBOWSKA-SZATKOWSKA, LUDMIŁA, et al.
Publicado: (2014)

Retrospective Analysis of Intravaginal Brachytherapy in Adjuvant Treatment of Early Endometrial Cancer
por: Cisek, Paweł, et al.
Publicado: (2018)

Canis MitoSNP database: a functional tool useful for comparative analyses of human and canine mitochondrial genomes
por: Kowal, Krzysztof, et al.
Publicado: (2023)

Interstitial HDR Brachytherapy in the Treatment of Non-Melanocytic Skin Cancers around the Eye
por: Cisek, Paweł, et al.
Publicado: (2021)

Identification of additional mitochondrial DNA mutations in canine mast cell tumours
por: Śmiech, Anna, et al.
Publicado: (2016)

Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer
por: Op den Kamp, Céline M. H., et al.
Publicado: (2014)

The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer
por: Lee, Hyo Chun, et al.
Publicado: (2014)

S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial
por: Yao, Lei, et al.
Publicado: (2015)

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
por: Koukourakis, M I, et al.
Publicado: (1999)

Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
por: Ohyanagi, F, et al.
Publicado: (2009)

Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
por: Kerner, Gerald SMA, et al.
Publicado: (2014)

A retrospective study of concurrent radiotherapy plus S-1 for treating advanced non-small cell lung cancer
por: Zhao, Dejun, et al.
Publicado: (2018)

Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer
por: Landman, Yosef, et al.
Publicado: (2021)

Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy
por: Grodzka, Anna, et al.
Publicado: (2023)

Mitochondrial DNA Changes in Respiratory Complex I Genes in Brain Gliomas
por: Kozakiewicz, Paulina, et al.
Publicado: (2023)

Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer
por: Oshita, F, et al.
Publicado: (2010)

Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy
por: Ouyang, Wei-Wei, et al.
Publicado: (2014)

Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
por: Liew, Mun Sem, et al.
Publicado: (2013)

Concurrent chemo-radiotherapy for unresectable non–small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?
por: Yoo, Gyu Sang, et al.
Publicado: (2019)

Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy
por: Mori, Masataka, et al.
Publicado: (2023)

Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer
por: Ardizzoni, A, et al.
Publicado: (1999)

Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments]
por: Yokoyama, A., et al.
Publicado: (1998)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Meta-Analysis
por: Qin, Hong, et al.
Publicado: (2014)

Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer
por: Takemoto, Shinnosuke, et al.
Publicado: (2017)

Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy
por: Li, Qingsong, et al.
Publicado: (2023)

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study
por: Jia, Zhen, et al.
Publicado: (2023)

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
por: Yamada, M, et al.
Publicado: (2002)

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection
por: Koukourakis, M I, et al.
Publicado: (2002)

Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
por: Fr Brunsvig, Paal, et al.
Publicado: (2007)

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report
por: Hsieh, Chen-Hsi, et al.
Publicado: (2010)

Concurrent use of nivolumab and radiotherapy for patients with metastatic non-small cell lung cancer and renal cell carcinoma with oligometastatic disease progression on nivolumab
por: Ansari, Jawaher, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o8fo5et0jgu8psn930drskdjfk